The issues in the cannabis industry predate the COVID-19 pandemic. Over the past year, pot companies have generally delivered subpar financial results, and their performances on the stock market haven't been much better. Aphria (NASDAQ: APHA), one of the largest cannabis companies by market cap, has also had its problems inlcuding attacks by short sellers and concerning acquisitions and subsequent writedowns.
Aphria has seemed to put this episode behind it. Since August 2019, shares of the Ontario-based pot grower are down by 24.6%, compared with a decline of 52.1% for the Horizons Marijuana Life Sciences ETF (OTC: HMLSF) -- an industry benchmark; both have underperformed compared to the S&P 500, which is up by 18.45% over the same period. Is now a good time to buy shares of Aphria? Let's look into the company's most recent financial results, as well as its overall business, and decide.
Source Fool.com